Medilloyd Medicament Private Limited, a under cirp private limited company, was established on 20 April 2012 in Cuttack, Orissa, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U24230OR2012PTC015269. Registered under ROC Roc Cuttack. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹1.00 Cr.
It upholds a compliant status. Its leadership includes Subhalaxmi Jena (Director), Shiba Prasanna Jena (Managing Director). Past directors included Jayant Kumar Patnaik. It holds ₹6.85 Cr open charges and ₹2.70 Cr settled loans. Its latest AGM occurred on 31 December 2020, with the balance sheet filed on 31 March 2020. It is based at Side Lane Of Sbi, Hyderabad Kanika Chhak, Tulsipur, Cuttack, Orissa, 753008.
U24230OR2012PTC015269
015269
20 April 2012
₹1.00 Cr
₹1.00 Cr
Roc Cuttack
Unlisted
Under Cirp
Explore comprehensive insights into Medilloyd Medicament Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Subhalaxmi Jena | Director | 20 Apr 2012 | Current |
| Shiba Prasanna Jena | Managing Director | 20 Apr 2012 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 Aug 2013 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Medilloyd Medicament Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 11.49% increase. The company also saw a slight decrease in profitability, with a 8.07% decrease in profit. The company's net worth moved up by a moderate rise of 5.05%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2020, Medilloyd Medicament had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹68,500,000.00
₹27,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Mar 2017 | Others | ₹4.10 Cr | Open |
| 24 Sep 2015 | Dcb Bank Limited | ₹2.75 Cr | Open |
| 24 Feb 2014 | Canara Bank | ₹2.70 Cr | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Medilloyd Medicament, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Medilloyd Medicament, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medilloyd Medicament's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Medilloyd Medicament Private Limited last Annual general meeting of members was held on 31 Dec 2020 as per latest MCA records. was recorded as a recent event.
The activity A charge with Others of Rs. 4.10 Cr registered on 28 Mar 2017 with Charge ID 100093459 was modified on 05 Aug 2020. was completed.
The activity Medilloyd Medicament Private Limited has filed its annual Financial statements for the year ended 31 Mar 2020 with Roc Cuttack. was completed.
Progress on A charge with Others amounted to Rs. 4.10 Cr with Charge ID 100093459 was registered on 28 Mar 2017. was documented.
Progress on A charge registered on 24 Feb 2014 via Charge ID 10487845 with Canara Bank was fully satisfied on 20 Feb 2017. was documented.
The activity A charge with Dcb Bank Limited amounted to Rs. 2.75 Cr with Charge ID 10608189 was registered on 24 Sep 2015. was completed.
The CIN of Medilloyd Medicament Private Limited is U24230OR2012PTC015269.
Medilloyd Medicament Private Limited is headquartered at Side Lane Of Sbi, Hyderabad Kanika Chhak, Tulsipur, Cuttack, Orissa, 753008.
Medilloyd Medicament Private Limited was incorporated on 20 April 2012.
The current directors of Medilloyd Medicament Private Limited are
The primary industry of Medilloyd Medicament Private Limited is Trade.
Medilloyd Medicament Private Limited is unlisted.
The authorized capital of Medilloyd Medicament Private Limited is ₹1.00 Cr, and the paid-up capital is ₹1.00 Cr.
The compliance status of Medilloyd Medicament Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX